Skip to content
Pre-Activity Survey
1.
Which of the following is not a key component of overactive bladder symptoms?
Urgency
Nocturia
Inability to completely empty bladder
Frequency
2.
Risk factors for OAB include all of the following except:
Obesity
Older age
Diabetes mellitus
Hyperlipidemia
3.
Which of the following should be included in the initial OAB work-up?
Urodynamics
Urinalysis
Cystoscopy
Bladder ultrasound
4.
Antimuscarinics should be used with caution in elderly patients with OAB due to an increased risk of:
Seizures
Gastrointestinal bleeding
Cognitive impairment
Bone density loss
5.
In the BESIDE study of adult OAB patients, mirabegron (50 mg) add-on therapy to low-dose solifenacin (5 mg) resulted in:
Similar effectiveness as low-dose solifenacin (5 mg)
Lower rates of treatment-emergent adverse events as compared to high-dose solifenacin (10 mg) monotherapy
Minimal effectiveness among older patients
Lower effectiveness as compared to high-dose solifenacin (10 mg)
6.
Referral to a urologist should be considered in the presence of any of the following findings except:
2 or more incontinent episodes per day
Hematuria
Pelvic pain
Neurogenic bladder
7.
According to the AUA/SUFU guidelines on OAB, for a patient with an inadequate response to behavioral therapy, second-line treatment can include all of the following except:
Oral antimuscarinic
Beta-3 agonist
Botulinum toxin injection
Combination therapy with an antimuscarinic and beta-3 agonist
8.
Name and Degree
(Required.)
9.
Email
(Required.)
10.
My practice setting is…
Private/Group Practice
Hospital
Clinic
Long-Term Care Facility
VA
Other (please specify)
11.
How long have you been in practice?
1-5 years
6-10 years
11-15 years
>15 years
12.
How many patients with overactive bladder symptoms do you see each week?
5 or less
6-15
16-25
>25
13.
How often do you refer OAB patients to a specialist for management?
Always
Frequently
Sometimes/When Needed
Rarely
Thank you for completing this survey.
